FDA Approval
History is made. Lonafarnib (now branded as ‘Zokinvy’) becomes the first-ever FDA-approved treatment for Progeria, placing it among fewer than 5% of rare diseases with an approved drug.
History is made. Lonafarnib (now branded as ‘Zokinvy’) becomes the first-ever FDA-approved treatment for Progeria, placing it among fewer than 5% of rare diseases with an approved drug.
